NCT05895266View on ClinicalTrials.gov

A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

June 23, 2023

Primary Completion Date

November 2, 2023

Study Completion Date

November 2, 2023

Conditions

Healthy Volunteer

Interventions

DRUG

ABBV-903

Oral Tablet

DRUG

Midazolam

Oral Liquid

Trial Locations (1)

60030

Acpru /Id# 254970, Grayslake

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY